{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T04:30:05Z","timestamp":1786595405199,"version":"build-2736575974"},"reference-count":123,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s10072-026-09276-x","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T01:49:26Z","timestamp":1785376166000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic factors of survival in corticobasal syndrome and corticobasal degeneration: A scoping review"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-3672-7849","authenticated-orcid":false,"given":"Muhammad S.","family":"Saim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2464-3630","authenticated-orcid":false,"given":"Hayder","family":"Al-Kazzaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5081-0573","authenticated-orcid":false,"given":"Haris","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,30]]},"reference":[{"key":"9276_CR1","first-page":"393","volume":"110","author":"JC Morris","year":"2013","unstructured":"Morris JC (2013) Neurodegenerative Disorders of Aging: The Down Side of Rising Longevity. Mo Med 110:393\u2013394","journal-title":"Mo Med"},{"key":"9276_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12051709","volume":"12","author":"J Van Schependom","year":"2023","unstructured":"Van Schependom J, D\u2019haeseleer M (2023) Advances in neurodegenerative diseases. J Clin Med 12:1709","journal-title":"J Clin Med"},{"key":"9276_CR3","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1002\/mds.25945","volume":"29","author":"T Pringsheim","year":"2014","unstructured":"Pringsheim T, Jette N, Frolkis A, Steeves TDL (2014) The prevalence of Parkinson\u2019s disease: a systematic review and meta-analysis. Mov Disord 29:1583\u20131590","journal-title":"Mov Disord"},{"key":"9276_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-017-0099-z","volume":"6","author":"P Maiti","year":"2017","unstructured":"Maiti P, Manna J, Dunbar GL (2017) Current understanding of the molecular mechanisms in Parkinson\u2019s disease: targets for potential treatments. Transl Neurodegener 6:28","journal-title":"Transl Neurodegener"},{"key":"9276_CR5","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1001\/jama.2019.22360","volume":"323","author":"MJ Armstrong","year":"2020","unstructured":"Armstrong MJ, Okun MS (2020) Diagnosis and Treatment of Parkinson Disease: A Review. JAMA 323:548\u2013560","journal-title":"JAMA"},{"key":"9276_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1362828","volume":"11","author":"Y Lou","year":"2024","unstructured":"Lou Y, Li Y, Chen Y (2024) The palliative care needs and experiences of patients with advanced Parkinson\u2019s disease: a qualitative scoping review. Front Med 11:1362828","journal-title":"Front Med"},{"key":"9276_CR7","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.3233\/JPD-202126","volume":"10","author":"AD van Halteren","year":"2020","unstructured":"van Halteren AD et al (2020) Personalized care management for persons with Parkinson\u2019s disease. J Parkinsons Dis 10:S11\u2013S20","journal-title":"J Parkinsons Dis"},{"key":"9276_CR8","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/S1474-4422(04)00936-6","volume":"3","author":"RK Mahapatra","year":"2004","unstructured":"Mahapatra RK, Edwards MJ, Schott JM, Bhatia KP (2004) Corticobasal degeneration. Lancet Neurol 3:736\u2013743","journal-title":"Lancet Neurol"},{"key":"9276_CR9","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1016\/S0140-6736(99)04137-9","volume":"354","author":"A Schrag","year":"1999","unstructured":"Schrag A, Ben-Shlomo Y, Quinn N (1999) Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study. Lancet 354:1771\u20131775","journal-title":"Lancet"},{"key":"9276_CR10","first-page":"53","volume":"82","author":"DM Togasaki","year":"2000","unstructured":"Togasaki DM, Tanner CM (2000) Epidemiologic aspects. Adv Neurol 82:53\u201359","journal-title":"Adv Neurol"},{"key":"9276_CR11","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/ene.13412","volume":"25","author":"AB Deutschl\u00e4nder","year":"2018","unstructured":"Deutschl\u00e4nder AB, Ross OA, Dickson DW, Wszolek ZK (2018) Atypical parkinsonian syndromes: a general neurologist\u2019s perspective. Eur J Neurol 25:41\u201358","journal-title":"Eur J Neurol"},{"key":"9276_CR12","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1097\/WCO.0b013e3283632da6","volume":"26","author":"M Stamelou","year":"2013","unstructured":"Stamelou M, Hoeglinger GU (2013) Atypical parkinsonism: an update. Curr Opin Neurol 26:401\u2013405","journal-title":"Curr Opin Neurol"},{"key":"9276_CR13","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.parkreldis.2018.10.009","volume":"59","author":"R Bhidayasiri","year":"2019","unstructured":"Bhidayasiri R, Sringean J, Reich SG, Colosimo C (2019) Red flags phenotyping: A systematic review on clinical features in atypical parkinsonian disorders. Parkinsonism Relat Disord 59:82\u201392","journal-title":"Parkinsonism Relat Disord"},{"key":"9276_CR14","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/mds.10459","volume":"18","author":"I Litvan","year":"2003","unstructured":"Litvan I et al (2003) SIC Task Force appraisal of clinical diagnostic criteria for parkinsonian disorders. Mov Disord 18:467\u2013486","journal-title":"Mov Disord"},{"key":"9276_CR15","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1212\/01.wnl.0000324625.00404.15","volume":"71","author":"S Gilman","year":"2008","unstructured":"Gilman S et al (2008) Second consensus statement on the diagnosis of multiple system atrophy. Neurology 71:670\u2013676","journal-title":"Neurology"},{"key":"9276_CR16","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1212\/WNL.0b013e31827f0fd1","volume":"80","author":"MJ Armstrong","year":"2013","unstructured":"Armstrong MJ et al (2013) Criteria for the diagnosis of corticobasal degeneration. Neurology 80:496\u2013503","journal-title":"Neurology"},{"key":"9276_CR17","doi-asserted-by":"crossref","unstructured":"Mark MH (2001) Lumping and splitting the Parkinson Plus syndromes: dementia with Lewy bodies, multiple system atrophy, progressive supranuclear palsy, and cortical-basal ganglionic degeneration. Neurol. Clin. 19, 607\u2013627, vi","DOI":"10.1016\/S0733-8619(05)70037-2"},{"key":"9276_CR18","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.conctc.2018.08.001","volume":"11","author":"DB Fogel","year":"2018","unstructured":"Fogel DB (2018) Factors associated with clinical trials that fail and opportunities for improving the likelihood of success: A review. Contemp Clin Trials Commun 11:156\u2013164","journal-title":"Contemp Clin Trials Commun"},{"key":"9276_CR19","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1055\/s-0034-1381739","volume":"34","author":"RM Tsai","year":"2014","unstructured":"Tsai RM, Boxer AL (2014) Clinical Trials: past, current and future for atypical parkinsonian syndromes. Semin Neurol 34:225\u2013234","journal-title":"Semin Neurol"},{"key":"9276_CR20","first-page":"66","volume":"1","author":"VC Constantinides","year":"2019","unstructured":"Constantinides VC, Paraskevas GP, Paraskevas PG, Stefanis L, Kapaki E (2019) Corticobasal degeneration and corticobasal syndrome: A review. Clin Park Relat Disord 1:66\u201371","journal-title":"Clin Park Relat Disord"},{"key":"9276_CR21","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1212\/CPJ.0000000000000026","volume":"4","author":"LM Chahine","year":"2014","unstructured":"Chahine LM, Rebeiz T, Rebeiz JJ, Grossman M, Gross RG (2014) Corticobasal syndrome. Neurol Clin Pract 4:304\u2013312","journal-title":"Neurol Clin Pract"},{"key":"9276_CR22","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1212\/WNL.40.8.1203","volume":"40","author":"DE Riley","year":"1990","unstructured":"Riley DE et al (1990) Cortical-basal ganglionic degeneration. Neurology 40:1203\u20131203","journal-title":"Neurology"},{"key":"9276_CR23","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1093\/brain\/awq123","volume":"133","author":"H Ling","year":"2010","unstructured":"Ling H et al (2010) Does corticobasal degeneration exist? A clinicopathological re-evaluation. Brain 133:2045\u20132057","journal-title":"Brain"},{"key":"9276_CR24","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1093\/jnen\/61.11.935","volume":"61","author":"DW Dickson","year":"2002","unstructured":"Dickson DW et al (2002) Office of Rare Diseases neuropathologic criteria for corticobasal degeneration. J Neuropathol Exp Neurol 61:935\u2013946","journal-title":"J Neuropathol Exp Neurol"},{"key":"9276_CR25","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s11940-024-00797-4","volume":"26","author":"C Delpirou Nouh","year":"2024","unstructured":"Delpirou Nouh C, Younes K (2024) Diagnosis and Management of Progressive Corticobasal Syndrome. Curr Treat Options Neurol 26:319\u2013338","journal-title":"Curr Treat Options Neurol"},{"key":"9276_CR26","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1590\/s1980-5764-2016dn1004003","volume":"10","author":"JB Parmera","year":"2016","unstructured":"Parmera JB, Rodriguez RD, Studart Neto A, Nitrini R, Brucki SMD (2016) Corticobasal syndrome: a diagnostic conundrum. Dement Neuropsychol 10:267\u2013275","journal-title":"Dement Neuropsychol"},{"key":"9276_CR27","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1212\/WNL.48.1.119","volume":"48","author":"I Litvan","year":"1997","unstructured":"Litvan I et al (1997) Accuracy of the Clinical Diagnosis of Corticobasal Degeneration: A Clinicopathologic Study. Neurology 48:119\u2013125","journal-title":"Neurology"},{"key":"9276_CR28","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1007\/s00415-005-0828-6","volume":"252","author":"O Moreaud","year":"2005","unstructured":"Moreaud O, Monavon A, Brutti\u2013Mairesse MP, Grand S, Lebas JF (2005) Creutzfeldt-Jakob disease mimicking corticobasal degeneration. J Neurol 252:1283\u20131284","journal-title":"J Neurol"},{"key":"9276_CR29","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1212\/WNL.55.9.1368","volume":"55","author":"A Kertesz","year":"2000","unstructured":"Kertesz A, Martinez-Lage P, Davidson W, Munoz DG (2000) The corticobasal degeneration syndrome overlaps progressive aphasia and frontotemporal dementia. Neurology 55:1368\u20131375","journal-title":"Neurology"},{"key":"9276_CR30","doi-asserted-by":"publisher","first-page":"S336","DOI":"10.1016\/S1353-8020(08)70027-0","volume":"13","author":"PM Wadia","year":"2007","unstructured":"Wadia PM, Lang AE (2007) The many faces of corticobasal degeneration. Parkinsonism Relat Disord 13:S336\u2013S340","journal-title":"Parkinsonism Relat Disord"},{"key":"9276_CR31","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1002\/mds.22558","volume":"24","author":"BP Shelley","year":"2009","unstructured":"Shelley BP, Hodges JR, Kipps CM, Xuereb JH, Bak TH (2009) Is the pathology of corticobasal syndrome predictable in life? Mov Disord 24:1593\u20131599","journal-title":"Mov Disord"},{"key":"9276_CR32","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1212\/WNL.53.4.795","volume":"53","author":"BF Boeve","year":"1999","unstructured":"Boeve BF et al (1999) Pathologic heterogeneity in clinically diagnosed corticobasal degeneration. Neurology 53:795\u2013795","journal-title":"Neurology"},{"key":"9276_CR33","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1002\/mds.1124","volume":"16","author":"Nj Cordato","year":"2001","unstructured":"Cordato Nj et al (2001) Corticobasal syndrome with tau pathology. Mov Disord 16:656\u2013667","journal-title":"Mov Disord"},{"key":"9276_CR34","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1002\/ana.10570","volume":"54","author":"BF Boeve","year":"2003","unstructured":"Boeve BF, Lang AE, Litvan I (2003) Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia. Ann Neurol 54:S15\u2013S19","journal-title":"Ann Neurol"},{"key":"9276_CR35","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/ana.22424","volume":"70","author":"SE Lee","year":"2011","unstructured":"Lee SE et al (2011) Clinicopathological correlations in corticobasal degeneration. Ann Neurol 70:327\u2013340","journal-title":"Ann Neurol"},{"key":"9276_CR36","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1136\/practneurol-2020-002835","volume":"21","author":"D Wilson","year":"2021","unstructured":"Wilson D, Heron CL, Anderson T (2021) Corticobasal syndrome: a practical guide. Pract Neurol 21:276\u2013285","journal-title":"Pract Neurol"},{"key":"9276_CR37","doi-asserted-by":"publisher","first-page":"205031212110009","DOI":"10.1177\/20503121211000918","volume":"9","author":"M Akdeniz","year":"2021","unstructured":"Akdeniz M, Yard\u0131mc\u0131 B, Kavukcu E (2021) Ethical considerations at the end-of-life care. SAGE Open Med 9:20503121211000918","journal-title":"SAGE Open Med"},{"key":"9276_CR38","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3390\/healthcare7020063","volume":"7","author":"DW Sherman","year":"2019","unstructured":"Sherman DW (2019) A Review of the Complex Role of Family Caregivers as Health Team Members and Second-Order Patients. Healthcare 7:63","journal-title":"Healthcare"},{"key":"9276_CR39","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","volume":"169","author":"AC Tricco","year":"2018","unstructured":"Tricco AC et al (2018) PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Ann Intern Med 169:467\u2013473","journal-title":"Ann Intern Med"},{"key":"9276_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.mex.2021.101375","volume":"8","author":"KK Westphaln","year":"2021","unstructured":"Westphaln KK et al (2021) From Arksey and O\u2019Malley and beyond: customizations to enhance a team-based, mixed approach to scoping review methodology. MethodsX 8:101375","journal-title":"MethodsX"},{"key":"9276_CR41","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/1364557032000119616","volume":"8","author":"H Arksey","year":"2005","unstructured":"Arksey H, O\u2019Malley L (2005) Scoping studies: towards a methodological framework. Int J Soc Res Methodol 8:19\u201332","journal-title":"Int J Soc Res Methodol"},{"key":"9276_CR42","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1186\/s13643-021-01821-3","volume":"10","author":"MDJ Peters","year":"2021","unstructured":"Peters MDJ et al (2021) Scoping reviews: reinforcing and advancing the methodology and application. Syst Rev 10:263","journal-title":"Syst Rev"},{"key":"9276_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2024.111572","volume":"176","author":"D Pollock","year":"2024","unstructured":"Pollock D et al (2024) \u2018How-to\u2019: scoping review? J Clin Epidemiol 176:111572","journal-title":"J Clin Epidemiol"},{"key":"9276_CR44","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/jrsm.1378","volume":"11","author":"M Gusenbauer","year":"2020","unstructured":"Gusenbauer M, Haddaway NR (2020) Which academic search systems are suitable for systematic reviews or meta-analyses? Evaluating retrieval qualities of Google Scholar, PubMed, and 26 other resources. Res Synth Methods 11:181\u2013217","journal-title":"Res Synth Methods"},{"key":"9276_CR45","unstructured":"Covidence systematic review software (2025) Veritas Health Innov"},{"key":"9276_CR46","doi-asserted-by":"publisher","first-page":"c83","DOI":"10.1159\/000324758","volume":"119","author":"VS Stel","year":"2011","unstructured":"Stel VS, Dekker FW, Tripepi G, Zoccali C, Jager KJ (2011) Survival analysis I: the Kaplan-Meier method. Nephron Clin Pract 119:c83\u201388","journal-title":"Nephron Clin Pract"},{"key":"9276_CR47","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/sj.bjc.6601118","volume":"89","author":"TG Clark","year":"2003","unstructured":"Clark TG, Bradburn MJ, Love SB, Altman DG (2003) Survival analysis part I: basic concepts and first analyses. Br J Cancer 89:232\u2013238","journal-title":"Br J Cancer"},{"key":"9276_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/frma.2023.1268045","volume":"8","author":"N Shaheen","year":"2023","unstructured":"Shaheen N et al (2023) Appraising systematic reviews: a comprehensive guide to ensuring validity and reliability. Front Res Metr Anal 8:1268045","journal-title":"Front Res Metr Anal"},{"key":"9276_CR49","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71","journal-title":"BMJ"},{"key":"9276_CR50","doi-asserted-by":"crossref","unstructured":"Aiba I et al (2023) Clinical course of pathologically confirmed corticobasal degeneration and corticobasal syndrome. Brain Commun 5(6):fcad296","DOI":"10.1093\/braincomms\/fcae028"},{"key":"9276_CR51","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/ane.13116","volume":"140","author":"R Constantinescu","year":"2019","unstructured":"Constantinescu R, Rosengren L, Eriksson B, Blennow K, Axelsson M (2019) Cerebrospinal fluid neurofilament light and tau protein as mortality biomarkers in parkinsonism. Acta Neurol Scand 140:147\u2013156","journal-title":"Acta Neurol Scand"},{"key":"9276_CR52","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1136\/jnnp-2020-324903","volume":"92","author":"AG Murley","year":"2021","unstructured":"Murley AG et al (2021) Predicting loss of independence and mortality in frontotemporal lobar degeneration syndromes. J Neurol Neurosurg Psychiatry 92:737\u2013744","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9276_CR53","first-page":"179","volume":"10","author":"CD Stang","year":"2020","unstructured":"Stang CD et al (2020) Incidence and Trends of Progressive Supranuclear Palsy and Corticobasal Syndrome: A Population-Based Study. J Park Dis 10:179\u2013184","journal-title":"J Park Dis"},{"key":"9276_CR54","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.parkreldis.2007.09.006","volume":"14","author":"WA VanVoorst","year":"2008","unstructured":"VanVoorst WA et al (2008) Neuropsychological findings in clinically atypical autopsy confirmed corticobasal degeneration and progressive supranuclear palsy. Parkinsonism Relat Disord 14:376\u2013378","journal-title":"Parkinsonism Relat Disord"},{"key":"9276_CR55","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1136\/jnnp.64.2.184","volume":"64","author":"G Wenning","year":"1998","unstructured":"Wenning G et al (1998) Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination. J Neurol Neurosurg Psychiatry 64:184\u2013189","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9276_CR56","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1055\/s-0042-1744120","volume":"13","author":"T Pani","year":"2022","unstructured":"Pani T, Nayak S (2022) The Non-motor Symptoms, Disability Progression, and Survival Analysis of Atypical Parkinsonism: Case Series from Eastern India and Brief Review of Literature. J Neurosci Rural Pract 13:276\u2013282","journal-title":"J Neurosci Rural Pract"},{"key":"9276_CR57","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.parkreldis.2013.01.002","volume":"19","author":"N Cushing","year":"2013","unstructured":"Cushing N et al (2013) Disability in atypical parkinsonian syndromes is more dependent on memory dysfunction than motor symptoms. Parkinsonism Relat Disord 19:436\u2013440","journal-title":"Parkinsonism Relat Disord"},{"key":"9276_CR58","doi-asserted-by":"publisher","first-page":"e1547","DOI":"10.1212\/WNL.0000000000007249","volume":"92","author":"CJ Lansdall","year":"2019","unstructured":"Lansdall CJ et al (2019) Prognostic importance of apathy in syndromes associated with frontotemporal lobar degeneration. Neurology 92:e1547\u2013e1557","journal-title":"Neurology"},{"key":"9276_CR59","doi-asserted-by":"publisher","first-page":"4239","DOI":"10.1002\/hbm.26342","volume":"44","author":"DJ Whiteside","year":"2023","unstructured":"Whiteside DJ et al (2023) Network connectivity and structural correlates of survival in progressive supranuclear palsy and corticobasal syndrome. Hum Brain Mapp 44:4239\u20134255","journal-title":"Hum Brain Mapp"},{"key":"9276_CR60","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1093\/brain\/117.5.1183","volume":"117","author":"JO Rinne","year":"1994","unstructured":"Rinne JO, Lee MS, Thompson PD, Marsden CD (1994) Corticobasal degeneration: A clinical study of 36 cases. Brain 117:1183\u20131196","journal-title":"Brain"},{"key":"9276_CR61","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1212\/WNL.0000000000002638","volume":"86","author":"ITS Coyle-Gilchrist","year":"2016","unstructured":"Coyle-Gilchrist ITS et al (2016) Prevalence, characteristics, and survival of frontotemporal lobar degeneration syndromes. Neurology 86:1736\u20131743","journal-title":"Neurology"},{"issue":"2","key":"9276_CR62","doi-asserted-by":"publisher","first-page":"II1","DOI":"10.1007\/BF03161075","volume":"246","author":"I Litvan","year":"1999","unstructured":"Litvan I et al (1999) Clinical features differentiating patients with postmortem confirmed progressive supranuclear palsy and corticobasal degeneration. J Neurol 246(2):II1\u20135","journal-title":"J Neurol"},{"key":"9276_CR63","doi-asserted-by":"publisher","DOI":"10.1111\/ene.16258","volume":"31","author":"C Kobylecki","year":"2024","unstructured":"Kobylecki C et al (2024) Frequency and outcomes of gastrostomy insertion in a longitudinal cohort study of atypical parkinsonism. Eur J Neurol 31:e16258","journal-title":"Eur J Neurol"},{"key":"9276_CR64","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.biopsych.2024.01.018","volume":"95","author":"D Urso","year":"2024","unstructured":"Urso D et al (2024) Nucleus Basalis of Meynert Degeneration Predicts Cognitive Decline in Corticobasal Syndrome. Biol Psychiatry 95:1048\u20131054","journal-title":"Biol Psychiatry"},{"key":"9276_CR65","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1212\/WNL.0000000000009734","volume":"95","author":"N Sakae","year":"2020","unstructured":"Sakae N et al (2020) Clinical and pathologic features of cognitive-predominant corticobasal degeneration. Neurology 95:e35\u2013e45","journal-title":"Neurology"},{"key":"9276_CR66","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1212\/WNL.53.9.1969","volume":"53","author":"DA Grimes","year":"1999","unstructured":"Grimes DA, Lang AE, Bergeron CB (1999) Dementia as the most common presentation of cortical-basal ganglionic degeneration. Neurology 53:1969\u20131969","journal-title":"Neurology"},{"key":"9276_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2024.123212","volume":"466","author":"D Tahara","year":"2024","unstructured":"Tahara D et al (2024) Clinical characteristics of Japanese patients with corticobasal degeneration. J Neurol Sci 466:123212","journal-title":"J Neurol Sci"},{"key":"9276_CR68","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.parkreldis.2009.11.013","volume":"16","author":"A Hassan","year":"2010","unstructured":"Hassan A et al (2010) Symmetric corticobasal degeneration (S-CBD). Parkinsonism Relat Disord 16:208\u2013214","journal-title":"Parkinsonism Relat Disord"},{"key":"9276_CR69","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s00401-019-02119-4","volume":"139","author":"H Ling","year":"2020","unstructured":"Ling H et al (2020) Fulminant corticobasal degeneration: a distinct variant with predominant neuronal tau aggregates. Acta Neuropathol (Berl) 139:717\u2013734","journal-title":"Acta Neuropathol (Berl)"},{"key":"9276_CR70","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/psyg.12054","volume":"14","author":"C Ikeda","year":"2014","unstructured":"Ikeda C et al (2014) Corticobasal degeneration initially developing motor versus non-motor symptoms: a comparative clinicopathological study. Psychogeriatrics 14:152\u2013164","journal-title":"Psychogeriatrics"},{"key":"9276_CR71","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1111\/ene.14800","volume":"28","author":"J V\u00f6glein","year":"2021","unstructured":"V\u00f6glein J et al (2021) First symptom guides diagnosis and prognosis in neurodegenerative diseases\u2014a retrospective study of autopsy proven cases. Eur J Neurol 28:1801\u20131811","journal-title":"Eur J Neurol"},{"key":"9276_CR72","unstructured":"Gibb WRG, Luthert PJ, Marsden C. D. CORTICOBASAL DEGENERATION"},{"key":"9276_CR73","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1097\/NEN.0000000000000022","volume":"73","author":"S Tatsumi","year":"2014","unstructured":"Tatsumi S et al (2014) Argyrophilic Grains Are Reliable Disease-Specific Features of Corticobasal Degeneration. J Neuropathol Exp Neurol 73:30\u201338","journal-title":"J Neuropathol Exp Neurol"},{"key":"9276_CR74","doi-asserted-by":"publisher","first-page":"e289","DOI":"10.1212\/WNL.0000000000207397","volume":"101","author":"D Shir","year":"2023","unstructured":"Shir D et al (2023) Clinicoradiologic and Neuropathologic Evaluation of Corticobasal Syndrome. Neurology 101:e289\u2013e299","journal-title":"Neurology"},{"key":"9276_CR75","first-page":"100279","volume":"11","author":"H Takigawa","year":"2024","unstructured":"Takigawa H et al (2024) Japanese longitudinal biomarker study in progressive supranuclear palsy and corticobasal degeneration: Clinical features of the first registered patients and short-term follow-up analysis. Clin Park Relat Disord 11:100279","journal-title":"Clin Park Relat Disord"},{"key":"9276_CR76","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1001\/archneur.58.2.259","volume":"58","author":"J M\u00fcller","year":"2001","unstructured":"M\u00fcller J et al (2001) Progression of dysarthria and dysphagia in postmortem-confirmed parkinsonian disorders. Arch Neurol 58:259\u2013264","journal-title":"Arch Neurol"},{"key":"9276_CR77","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1136\/jnnp.2005.074070","volume":"77","author":"DR Williams","year":"2006","unstructured":"Williams DR, Watt HC, Lees AJ (2006) Predictors of falls and fractures in bradykinetic rigid syndromes: a retrospective study. J Neurol Neurosurg Psychiatry 77:468\u2013473","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9276_CR78","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.baga.2015.12.003","volume":"6","author":"F Amtage","year":"2016","unstructured":"Amtage F et al (2016) Metabolic patterns associated with survival in PSP\/CBS: An 18FDG PET voxel-based analysis. Basal Ganglia 6:45\u201351","journal-title":"Basal Ganglia"},{"key":"9276_CR79","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/neup.12876","volume":"43","author":"Y Horimoto","year":"2023","unstructured":"Horimoto Y et al (2023) A descriptive study of Parkinson disease and atypical parkinsonisms in the Annuals of the Pathological Autopsy Cases in Japan. Neuropathology 43:297\u2013305","journal-title":"Neuropathology"},{"key":"9276_CR80","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.nbd.2008.09.027","volume":"33","author":"C Cruchaga","year":"2009","unstructured":"Cruchaga C et al (2009) 5\u2032-upstream variants of CRHR1 and MAPT genes associated with age at onset in progressive supranuclear palsy and cortical basal degeneration. Neurobiol Dis 33:164\u2013170","journal-title":"Neurobiol Dis"},{"key":"9276_CR81","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s00415-025-12990-9","volume":"272","author":"DP Vaughan","year":"2025","unstructured":"Vaughan DP et al (2025) Analysis of C9orf72 repeat length in progressive supranuclear palsy, corticobasal syndrome, corticobasal degeneration, and atypical parkinsonism. J Neurol 272:293","journal-title":"J Neurol"},{"key":"9276_CR82","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1002\/mds.22804","volume":"25","author":"I Litvan","year":"2010","unstructured":"Litvan I, Chism A, Litvan J, Cambon A, Hutton M (2010) H1\/H1 genotype influences symptom severity in corticobasal syndrome. Mov Disord 25:760\u2013763","journal-title":"Mov Disord"},{"key":"9276_CR83","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1212\/01.wnl.0000259519.78480.c3","volume":"68","author":"R Murray","year":"2007","unstructured":"Murray R et al (2007) Cognitive and motor assessment in autopsy-proven corticobasal degeneration. Neurology 68:1274\u20131283","journal-title":"Neurology"},{"key":"9276_CR84","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1212\/01.wnl.0000191307.69661.c3","volume":"66","author":"KA Josephs","year":"2006","unstructured":"Josephs KA et al (2006) Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP. Neurology 66:41\u201348","journal-title":"Neurology"},{"key":"9276_CR85","first-page":"183","volume":"82","author":"I Litvan","year":"2000","unstructured":"Litvan I, Grimes DA, Lang AE (2000) Phenotypes and prognosis: clinicopathologic studies of corticobasal degeneration. Adv Neurol 82:183\u2013196","journal-title":"Adv Neurol"},{"key":"9276_CR86","first-page":"93","volume":"83","author":"CM Doherty","year":"2014","unstructured":"Doherty CM, Forbes RB (2014) Diagnostic Lumbar Puncture. Ulster Med J 83:93\u2013102","journal-title":"Ulster Med J"},{"key":"9276_CR87","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1236296","volume":"14","author":"D-W Ryu","year":"2023","unstructured":"Ryu D-W, Han K, Cho A-H (2023) Mortality and causes of death in patients with Parkinson\u2019s disease: a nationwide population-based cohort study. Front Neurol 14:1236296","journal-title":"Front Neurol"},{"key":"9276_CR88","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/jnnp-2020-323939","volume":"92","author":"U Akbar","year":"2021","unstructured":"Akbar U et al (2021) Prognostic predictors relevant to end-of-life palliative care in Parkinson\u2019s disease and related disorders: a systematic review. J Neurol Neurosurg Psychiatry 92:629\u2013636","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9276_CR89","first-page":"1","volume":"8","author":"MC Gonzalez","year":"2022","unstructured":"Gonzalez MC, Dalen I, Maple-Gr\u00f8dem J, Tysnes O-B, Alves G (2022) Parkinson\u2019s disease clinical milestones and mortality. Npj Park Dis 8:1\u20135","journal-title":"Npj Park Dis"},{"key":"9276_CR90","doi-asserted-by":"publisher","first-page":"e2045","DOI":"10.1212\/WNL.0000000000006576","volume":"91","author":"D B\u00e4ckstr\u00f6m","year":"2018","unstructured":"B\u00e4ckstr\u00f6m D et al (2018) Early predictors of mortality in parkinsonism and Parkinson disease: A population-based study. Neurology 91:e2045\u2013e2056","journal-title":"Neurology"},{"key":"9276_CR91","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1002\/mds.25898","volume":"29","author":"AD Macleod","year":"2014","unstructured":"Macleod AD, Taylor KSM, Counsell CE (2014) Mortality in Parkinson\u2019s disease: a systematic review and meta-analysis. Mov Disord Off J Mov Disord Soc 29:1615\u20131622","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"9276_CR92","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1212\/CON.0000000000001158","volume":"28","author":"A Pantelyat","year":"2022","unstructured":"Pantelyat A (2022) Progressive Supranuclear Palsy and Corticobasal Syndrome. Contin Lifelong Learn Neurol 28:1364","journal-title":"Contin Lifelong Learn Neurol"},{"key":"9276_CR93","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1002\/mdc3.12900","volume":"7","author":"E Bayram","year":"2020","unstructured":"Bayram E, Dickson DW, Reich SG, Litvan I (2020) Pathology-Proven Corticobasal Degeneration Presenting as Richardson\u2019s Syndrome. Mov Disord Clin Pract 7:267\u2013272","journal-title":"Mov Disord Clin Pract"},{"key":"9276_CR94","doi-asserted-by":"publisher","first-page":"826676","DOI":"10.3389\/fneur.2022.826676","volume":"13","author":"K Seibert","year":"2022","unstructured":"Seibert K, Smith H, Lapins A, Pytel P, Mastrianni JA (2022) A novel TBK1 variant (Lys694del) presenting with corticobasal syndrome in a family with FTD-ALS spectrum diseases: case report. Front Neurol. 2022 Mar 4;13:826676","journal-title":"Front Neurol"},{"key":"9276_CR95","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12883-021-02178-9","volume":"21","author":"D Yoo","year":"2021","unstructured":"Yoo D, Park S-H, Yu S, Ahn T-B (2021) An autopsy-proven case of Corticobasal degeneration heralded by Pontine infarction. BMC Neurol 21:148","journal-title":"BMC Neurol"},{"key":"9276_CR96","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1007\/s00415-014-7491-8","volume":"261","author":"S Yamashita","year":"2014","unstructured":"Yamashita S et al (2014) Concomitant accumulation of \u03b1-synuclein and TDP-43 in a patient with corticobasal degeneration. J Neurol 261:2209\u20132217","journal-title":"J Neurol"},{"key":"9276_CR97","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s00401-006-0093-5","volume":"112","author":"K Sakai","year":"2006","unstructured":"Sakai K et al (2006) Corticobasal degeneration with focal, massive tau accumulation in the subcortical white matter astrocytes. Acta Neuropathol (Berl) 112:341\u2013348","journal-title":"Acta Neuropathol (Berl)"},{"key":"9276_CR98","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/neup.12963","volume":"44","author":"K Yoshida","year":"2024","unstructured":"Yoshida K et al (2024) Corticobasal degeneration with visual hallucination as an initial symptom: A case report. Neuropathology 44:298\u2013303","journal-title":"Neuropathology"},{"key":"9276_CR99","doi-asserted-by":"publisher","first-page":"S61","DOI":"10.1212\/WNL.0b013e31820c34ca","volume":"76","author":"A Pantelyat","year":"2011","unstructured":"Pantelyat A et al (2011) Acalculia in autopsy-proven corticobasal degeneration. Neurology 76:S61\u2013S63","journal-title":"Neurology"},{"key":"9276_CR100","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1080\/13554790600977218","volume":"12","author":"R S\u00e1nchez-Valle","year":"2006","unstructured":"S\u00e1nchez-Valle R, Forman MS, Miller BL, Gorno-Tempini ML (2006) From progressive nonfluent aphasia to corticobasal syndrome: a case report of corticobasal degeneration. Neurocase 12:355\u2013359","journal-title":"Neurocase"},{"key":"9276_CR101","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1002\/ana.410400611","volume":"40","author":"C Bergeron","year":"1996","unstructured":"Bergeron C, Pollanen MS, Weyer L, Black SE, Lang AE (1996) Unusual clinical presentations of cortical-basal ganglionic degeneration. Ann Neurol 40:893\u2013900","journal-title":"Ann Neurol"},{"key":"9276_CR102","first-page":"559","volume":"48","author":"K Tsuchiya","year":"1996","unstructured":"Tsuchiya K et al (1996) [An unusual autopsy case of corticobasal degeneration\u2013with special reference to clinicopathological differentiation from progressive supranuclear palsy and slowly progressive aphasia]. No Shinkei 48:559\u2013565","journal-title":"No Shinkei"},{"key":"9276_CR103","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1111\/neup.12398","volume":"37","author":"Y Iwasaki","year":"2017","unstructured":"Iwasaki Y, Mori K, Ito M, Mimuro M, Yoshida M (2017) An autopsied case of corticobasal degeneration presenting with frontotemporal dementia followed by myoclonus. Neuropathology 37:569\u2013574","journal-title":"Neuropathology"},{"key":"9276_CR104","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1111\/neup.12188","volume":"35","author":"D Kondo","year":"2015","unstructured":"Kondo D et al (2015) An autopsied case of corticobasal degeneration showing severe cerebral atrophy over a protracted disease course of 16 years. Neuropathology 35:280\u2013288","journal-title":"Neuropathology"},{"key":"9276_CR105","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1212\/WNL.0000000000002491","volume":"86","author":"F Rodriguez-Porcel","year":"2016","unstructured":"Rodriguez-Porcel F et al (2016) Fulminant corticobasal degeneration: Agrypnia excitata in corticobasal syndrome. Neurology 86:1164\u20131166","journal-title":"Neurology"},{"key":"9276_CR106","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1007\/s004010100460","volume":"103","author":"Y Mizuno","year":"2002","unstructured":"Mizuno Y et al (2002) A case of clinically and neuropathologically atypical corticobasal degeneration with widespread iron deposition. Acta Neuropathol (Berl) 103:288\u2013294","journal-title":"Acta Neuropathol (Berl)"},{"key":"9276_CR107","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/1756-0500-7-264","volume":"7","author":"T Nissen","year":"2014","unstructured":"Nissen T, Wynn R (2014) The clinical case report: a review of its merits and limitations. BMC Res Notes 7:264","journal-title":"BMC Res Notes"},{"key":"9276_CR108","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.parkreldis.2017.05.022","volume":"41","author":"M Moscovich","year":"2017","unstructured":"Moscovich M et al (2017) Death certificate data and causes of death in patients with parkinsonism. Parkinsonism Relat Disord 41:99\u2013103","journal-title":"Parkinsonism Relat Disord"},{"key":"9276_CR109","doi-asserted-by":"crossref","unstructured":"Burrell JR, Hodges JR Chapter 12 - Falls in frontotemporal dementia and related syndromes. in Handbook of Clinical Neurology (eds Day, B. L. & Lord, S. R.) vol. 159 195\u2013203 (Elsevier, 2018)","DOI":"10.1016\/B978-0-444-63916-5.00012-4"},{"key":"9276_CR110","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.1007\/s00415-024-12280-w","volume":"271","author":"DMA Swallow","year":"2024","unstructured":"Swallow DMA, Counsell CE (2024) Accuracy of routinely collected hospital administrative discharge data and death certificate ICD-10 diagnostic coding in progressive supranuclear palsy and corticobasal syndrome: a systematic review and validation study. J Neurol 271:2929\u20132937","journal-title":"J Neurol"},{"key":"9276_CR111","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1212\/WNL.0b013e3181e04070","volume":"74","author":"E Mioshi","year":"2010","unstructured":"Mioshi E, Hsieh S, Savage S, Hornberger M, Hodges JR (2010) Clinical staging and disease progression in frontotemporal dementia. Neurology 74:1591\u20131597","journal-title":"Neurology"},{"key":"9276_CR112","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1007\/s00415-014-7389-5","volume":"261","author":"N Huang","year":"2014","unstructured":"Huang N, Hornberger M, Hodges JR, Burrell JR (2014) Measuring disease progression in corticobasal syndrome. J Neurol 261:1598\u20131605","journal-title":"J Neurol"},{"key":"9276_CR113","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.parkreldis.2018.08.025","volume":"60","author":"C Brittain","year":"2019","unstructured":"Brittain C et al (2019) Severity dependent distribution of impairments in PSP and CBS: Interactive visualizations. Parkinsonism Relat Disord 60:138\u2013145","journal-title":"Parkinsonism Relat Disord"},{"key":"9276_CR114","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.2147\/NDT.S178263","volume":"14","author":"D Belvisi","year":"2018","unstructured":"Belvisi D et al (2018) Neuropsychiatric disturbances in atypical parkinsonian disorders. Neuropsychiatr Dis Treat 14:2643\u20132656","journal-title":"Neuropsychiatr Dis Treat"},{"key":"9276_CR115","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.jad.2020.07.127","volume":"276","author":"R Ou","year":"2020","unstructured":"Ou R et al (2020) Suicidal and death ideation in patients with progressive supranuclear palsy and corticobasal syndrome. J Affect Disord 276:1061\u20131068","journal-title":"J Affect Disord"},{"key":"9276_CR116","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1001\/archneur.55.7.957","volume":"55","author":"K Kompoliti","year":"1998","unstructured":"Kompoliti K et al (1998) Clinical presentation and pharmacological therapy in corticobasal degeneration. Arch Neurol 55:957\u2013961","journal-title":"Arch Neurol"},{"key":"9276_CR117","doi-asserted-by":"publisher","first-page":"26","DOI":"10.12968\/hmed.2010.71.1.45969","volume":"71","author":"SK Wilcox","year":"2010","unstructured":"Wilcox SK (2010) Extending palliative care to patients with Parkinson\u2019s disease. Br J Hosp Med 71:26\u201330","journal-title":"Br J Hosp Med"},{"key":"9276_CR118","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1177\/1049909114565110","volume":"33","author":"J B\u00fckki","year":"2016","unstructured":"B\u00fckki J, N\u00fcbling G, Lorenzl S (2016) Managing Advanced Progressive Supranuclear Palsy and Corticobasal Degeneration in a Palliative Care Unit: Admission Triggers and Outcomes. Am J Hosp Palliat Care 33:477\u2013482","journal-title":"Am J Hosp Palliat Care"},{"key":"9276_CR119","doi-asserted-by":"publisher","first-page":"3464","DOI":"10.1007\/s00415-023-11629-x","volume":"270","author":"DMA Swallow","year":"2023","unstructured":"Swallow DMA, Counsell CE (2023) The evolution of diagnosis from symptom onset to death in progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) compared to Parkinson\u2019s disease (PD). J Neurol 270:3464\u20133474","journal-title":"J Neurol"},{"key":"9276_CR120","volume-title":"Parkinson\u2019s Disease: National Clinical Guideline for Diagnosis and Management in Primary and Secondary Care","author":"National Collaborating Centre for Chronic Conditions (UK)","year":"2006","unstructured":"National Collaborating Centre for Chronic Conditions (UK) (2006) Parkinson\u2019s Disease: National Clinical Guideline for Diagnosis and Management in Primary and Secondary Care. Royal College of Physicians (UK), London"},{"key":"9276_CR121","unstructured":"Higgins J, Green S (2011) Cochrane Risk of Bias Tool for Randomized Controlled Trials. in Cochrane Handbook for Systematic Reviews of Interventions"},{"key":"9276_CR122","doi-asserted-by":"publisher","first-page":"169","DOI":"10.4103\/tcmj.tcmj_218_20","volume":"34","author":"RY Lo","year":"2021","unstructured":"Lo RY (2021) Epidemiology of atypical parkinsonian syndromes. Tzu-Chi Med J 34:169\u2013181","journal-title":"Tzu-Chi Med J"},{"key":"9276_CR123","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1007\/s00415-020-10113-0","volume":"268","author":"H Shi","year":"2021","unstructured":"Shi H, Counsell C (2021) Accuracy of death certificates for recording parkinsonian syndromes and associated dementia. J Neurol 268:140\u2013146","journal-title":"J Neurol"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-026-09276-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-026-09276-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-026-09276-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T04:16:14Z","timestamp":1786594574000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-026-09276-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,30]]},"references-count":123,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["9276"],"URL":"https:\/\/doi.org\/10.1007\/s10072-026-09276-x","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,30]]},"assertion":[{"value":"12 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study is a systematic review based on previously published studies. Therefore, ethical approval and informed consent were not required. All included studies were conducted in accordance with established ethical standards.","order":1,"name":"Ethics","label":"Ethical approval <b>and Informed consent<\/b>","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest of any kind in the content of this article.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"664"}}